Truist Financial
PPH icon

Truist Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Truist Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,364
Closed -$246K – 2991
2026
Q1 		$246K Buy
2,364
+130
+6% +$13.8K ﹤0.01% 2525
2025
Q4 		$230K Buy
+2,234
New +$217K ﹤0.01% 2510

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Truist Financial's PPH Position: Q2 2026 in Review

Truist Financial sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2026, closing a stake of 2,364 shares — an estimated $246K sold.

Truist Financial first reported a position in PPH in Q4 2025 and held it in 2 quarters. The position peaked at $246K in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Truist Financial reported no remaining VanEck Pharmaceutical ETF position as of Q2 2026 after selling out during the quarter.
  • Truist Financial sold 2,364 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $246K.
  • Truist Financial first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and held it in 2 quarters.
  • Truist Financial's VanEck Pharmaceutical ETF position peaked at $246K in Q1 2026.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.